Literature DB >> 17591938

CYP1B1 mutation profile of Iranian primary congenital glaucoma patients and associated haplotypes.

Fereshteh Chitsazian1, Betsabeh Khoramian Tusi, Elahe Elahi, Heidar Amini Saroei, Mohammad H Sanati, Shahin Yazdani, Mohammad Pakravan, Navid Nilforooshan, Yadollah Eslami, Mohammad Ali Zare Mehrjerdi, Reza Zareei, Mahmood Jabbarvand, Ali Abdolahi, Ali R Lasheyee, Arash Etemadi, Behnaz Bayat, Mehdi Sadeghi, Mohammad M Banoei, Behnam Ghafarzadeh, Mohammad R Rohani, Akram Rismanchian, Yvonne Thorstenson, Mansoor Sarfarazi.   

Abstract

The mutation spectrum of CYP1B1 among 104 primary congenital glaucoma patients of the genetically heterogeneous Iranian population was investigated by sequencing. We also determined intragenic single nucleotide polymorphism (SNP) haplotypes associated with the mutations and compared these with haplotypes of other populations. Finally, the frequency distribution of the haplotypes was compared among primary congenital glaucoma patients with and without CYP1B1 mutations and normal controls. Genotype classification of six high-frequency SNPs was performed using the PHASE 2.0 software. CYP1B1 mutations in the Iranian patients were very heterogeneous. Nineteen nonconservative mutations associated with disease, and 10 variations not associated with disease were identified. Ten mutations and three variations not associated with disease were novel. The 13 novel variations make a notable contribution to the approximately 70 known variations in the gene. CYP1B1 mutations were identified in 70% of the patients. The four most common mutations were G61E, R368H, R390H, and R469W, which together constituted 76.2% of the CYP1B1 mutated alleles found. Six unique core SNP haplotypes were identified, four of which were common to the patients with and without CYP1B1 mutations and controls studied. Three SNP blocks determined the haplotypes. Comparison of haplotypes with those of other populations suggests a common origin for many of the mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591938      PMCID: PMC1899412          DOI: 10.2353/jmoldx.2007.060157

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  44 in total

1.  Identification of novel mutations causing familial primary congenital glaucoma in Indian pedigrees.

Authors:  Shirly G Panicker; Aramati B M Reddy; Anil K Mandal; Niyaz Ahmed; Hampapathalu A Nagarajaram; Seyed E Hasnain; Dorairajan Balasubramanian
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

2.  Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus.

Authors:  Arya Mani; Seyed-Mahmoud Meraji; Roozbeh Houshyar; Jayaram Radhakrishnan; Alaleh Mani; Mehrabeh Ahangar; Tayebeh M Rezaie; Mohammad-Ali Taghavinejad; Behrooz Broumand; Hongyu Zhao; Carol Nelson-Williams; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

3.  CYP1B1 gene analysis in primary congenital glaucoma in Indonesian and European patients.

Authors:  R Sitorus; S M Ardjo; B Lorenz; M Preising
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

4.  A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase.

Authors:  Paul Scheet; Matthew Stephens
Journal:  Am J Hum Genet       Date:  2006-02-17       Impact factor: 11.025

5.  Molecular genetics of primary congenital glaucoma in Brazil.

Authors:  Ivaylo R Stoilov; Vital P Costa; Jose P C Vasconcellos; Monica B Melo; Alberto J Betinjane; Jose C E Carani; Ernst V Oltrogge; Mansoor Sarfarazi
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

Review 6.  Clinical importance of the cytochromes P450.

Authors:  Daniel W Nebert; David W Russell
Journal:  Lancet       Date:  2002-10-12       Impact factor: 79.321

7.  Expression patterns of cytochrome P4501B1 (Cyp1b1) in FVB/N mouse eyes.

Authors:  Bassem A Bejjani; Li Xu; Dawna Armstrong; James R Lupski; Lixing W Reneker
Journal:  Exp Eye Res       Date:  2002-09       Impact factor: 3.467

8.  Novel cytochrome P4501B1 (CYP1B1) gene mutations in Japanese patients with primary congenital glaucoma.

Authors:  Y Mashima; Y Suzuki; Y Sergeev; Y Ohtake; T Tanino; I Kimura; H Miyata; M Aihara; H Tanihara; M Inatani; N Azuma; T Iwata; M Araie
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

9.  A novel frameshift founder mutation in the cytochrome P450 1B1 (CYP1B1) gene is associated with primary congenital glaucoma in Morocco.

Authors:  A Belmouden; R Melki; M Hamdani; K Zaghloul; A Amraoui; S Nadifi; O Akhayat; H-J Garchon
Journal:  Clin Genet       Date:  2002-10       Impact factor: 4.438

10.  Phenotype of cytochrome P4501B1 gene (CYP1B1) mutations in Japanese patients with primary congenital glaucoma.

Authors:  Y Ohtake; T Tanino; Y Suzuki; H Miyata; M Taomoto; N Azuma; H Tanihara; M Araie; Y Mashima
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

View more
  33 in total

1.  Carrier frequency of CYP1B1 mutations in the United States (an American Ophthalmological Society thesis).

Authors:  Janey L Wiggs; Anne M Langgurth; Keri F Allen
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

Review 2.  Analysis of CYP1B1 Gene Mutations in Patients with Primary Congenital Glaucoma.

Authors:  Leila Chouiter; Sellama Nadifi
Journal:  J Pediatr Genet       Date:  2017-04-21

3.  Role of CYP1B1, p.E229K and p.R368H mutations among 120 families with sporadic juvenile onset open-angle glaucoma.

Authors:  Viney Gupta; Bindu I Somarajan; Gagandeep Kaur Walia; Jasbir Kaur; Sunil Kumar; Shikha Gupta; Abadh K Chaurasia; Dinesh Gupta; Abhinav Kaushik; Aditi Mehta; Vipin Gupta; Arundhati Sharma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-22       Impact factor: 3.117

4.  Genetic analysis of patients with primary congenital glaucoma.

Authors:  Sedat Ava; Atılım Armağan Demirtaş; Mine Karahan; Seyfettin Erdem; Diclehan Oral; Uğur Keklikçi
Journal:  Int Ophthalmol       Date:  2021-03-21       Impact factor: 2.031

Review 5.  Primary congenital and developmental glaucomas.

Authors:  Carly J Lewis; Adam Hedberg-Buenz; Adam P DeLuca; Edwin M Stone; Wallace L M Alward; John H Fingert
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

6.  Screening of CYP1B1 and MYOC in Moroccan families with primary congenital glaucoma: three novel mutations in CYP1B1.

Authors:  Latifa Hilal; Soraya Boutayeb; Aziza Serrou; Loubna Refass-Buret; Hafsa Shisseh; Fatiha Bencherifa; Mohammed El Mzibri; Bouchra Benazzouz; Amina Berraho
Journal:  Mol Vis       Date:  2010-07-02       Impact factor: 2.367

7.  CYP1B1 gene mutations with incomplete penetrance in a Chinese pedigree with primary congenital glaucoma: a case report and review of literatures.

Authors:  Ling Chen; Lina Huang; Aineng Zeng; Jing He
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Mutational analysis of CYP1B1 gene in Iranian pedigrees with glaucoma reveals known and novel mutations.

Authors:  Babak Emamalizadeh; Yousef Daneshmandpour; Somayeh Kazeminasb; Ehsan Aghaei Moghadam; Zahra Bahmanpour; Elham Alehabib; Somayeh Alinaghi; Azadeh Doozandeh; Minoo Atakhorrami; Hossein Darvish
Journal:  Int Ophthalmol       Date:  2021-05-21       Impact factor: 2.031

9.  Genotyping results of Iranian PCG families suggests one or more PCG locus other than GCL3A, GCL3B, and GCL3C exist.

Authors:  Mehrnaz Narooie-Nejad; Fereshteh Chitsazian; Betsabeh Khoramian Tusi; Faride Mousavi; Massoud Houshmand; Mohammad R Rohani; Azam S Hosseinipour; Akram Rismanchian; Elahe Elahi
Journal:  Mol Vis       Date:  2009-10-22       Impact factor: 2.367

10.  Sex Bias in Primary Congenital Glaucoma Patients with and without CYP1B1 Mutations.

Authors:  Fatemeh Suri; Fereshteh Chitsazian; Betsabeh Khoramian-Tusi; Heidar Amini; Shahin Yazdani; Naveed Nilforooshan; S Jalal Zargar; Elahe Elahi
Journal:  J Ophthalmic Vis Res       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.